SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Roadster reveal, featuring a demo of SpaceX-developed thrusters that appeared to lift and maneuver the car, is driving attention. Traders are split between praising the engineering spectacle and questioning its practicality, road legality, and delayed path to production; some also speculate about a TeslaSpaceX merger, which remains unconfirmed.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Teslas Roadster reveal, including speculation about SpaceX rocket technology being used in the car, has driven attention, with traders also circulating unconfirmed TeslaSpaceX merger rumors. Bulls see the showcase as a sign of broader commercial potential, while skeptics question the technologys practicality and SpaceXs valuation amid recent volatility.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

RGCs sharp move has renewed speculation about another squeeze, with traders pointing to the companys tightly held shares, reportedly scarce and costly-to-borrow stock, and history of dramatic meme-stock swings. Others characterize the rally as a pump-and-dump and question its fundamentals, noting the lack of a clear new business catalyst.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives sharp rally has traders focused on its tokenization and RWA push, institutional-access developments, and buyback-and-burn mechanics as potential supports for demand and tighter supply. Bulls see room for further gains, while skeptics question whether the move can hold after volatile pullbacks; no single catalyst is confirmed as driving the price action.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is rallying on anticipation of the full Phase 3 melanoma cancer-vaccine data at ESMO, following positive topline results and a Goldman Sachs target increase. Traders are split between momentum-driven optimism and concerns that the run-up has outpaced fundamentals, with some warning of a sell-the-news pullback.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid a steep post-IPO decline and concerns that staggered share unlocks could add selling pressure, alongside weakness across AI and semiconductor stocks. Traders debate whether the drop is temporary supply and sector pressure or reflects valuation and OpenAI customer-concentration risks; bulls counter with the companys inference technology and demand potential.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas new U.S. beverage partnership with KFC is drawing attention as a win for KOs distribution footprint and a setback for longtime supplier PepsiCo; traders also point to the stocks recent highs and defensive appeal, while some caution that its run may be overextended.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Auroras five-year FMCSA exemption allowing cab-mounted warning beacons on its autonomous trucks is drawing attention as a regulatory milestone for driverless freight operations. Many traders view it as progress toward scaling, while others remain cautious about the companys path to meaningful revenue and the stocks volatility.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas move to fresh record highs, alongside a bullish analyst upgrade ahead of earnings, is driving attention. Traders are celebrating the breakout and call-option activity, while some caution that the sharp run-up could invite profit-taking.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is under pressure amid concern that Auvelitys early launch for Alzheimers-related agitation is not translating into prescription growth as quickly as investors expected, with traders also questioning sales execution and managements silence ahead of quarterly results. Bulls argue reported prescriptions may undercount demand because of samples and long-term-care channels, while others remain worried that the launch and path to profitability could disappoint.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
